ConvaTec Group (CNVVY) Stock Price, News & Analysis

Company Overview

ConvaTec Group is a global medical products and technologies company focused on developing therapies and technologies for the management of chronic health conditions. The company’s portfolio spans four core business areas—Advanced Wound Care, Ostomy Care, Continence & Critical Care, and Infusion Devices—which are designed to improve patient outcomes and enhance quality of life for people living with long-term health challenges. ConvaTec’s product range includes proprietary wound dressings, ostomy and continence management systems, and safety-engineered infusion sets.

Headquartered in Reading, United Kingdom, ConvaTec serves customers in over 100 countries through a network of manufacturing, distribution, and customer support operations. Its regional footprint covers North America, Europe & Turkey, Japan & Asia Pacific, and Emerging Markets, enabling the company to tailor its offerings to diverse healthcare environments and local regulatory requirements. ConvaTec collaborates with healthcare professionals, payers, and patient advocacy groups to drive innovations and improve care pathways for chronic conditions.

The company traces its origins to medical device activities within pharmaceutical firms in the 1970s and gained independence following a demerger from Bristol-Myers Squibb in 2008. ConvaTec subsequently completed an initial public offering on the London Stock Exchange in 2016, and its American Depositary Receipts trade on the U.S. over-the-counter market under the symbol CNVVY. Over the years, ConvaTec has expanded its capabilities through targeted research and development investments and partnerships aimed at advancing product performance and patient support services.

ConvaTec is led by Chief Executive Officer Karim Bitar, who has overseen strategic initiatives to strengthen the company’s innovation pipeline and global market presence since 2018. Under his leadership, ConvaTec continues to emphasize patient-centric design, digital health integration, and sustainable business practices. The company is guided by a board of directors and experienced management team committed to delivering long-term value for patients, healthcare systems, and shareholders.

Key Stats

• Today's Range: $12.86 to $12.93
• 50-Day Range: $12.27 to $14.80
• 52-Week Range: $10.77 to $16.65
• Volume: 15,279 shs
• Average Volume: 43,541 shs
• Market Capitalization: N/A
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

CNVVY Stock Analysis - Frequently Asked Questions

How have CNVVY shares performed this year?

ConvaTec Group's stock was trading at $11.44 at the beginning of 2025. Since then, CNVVY stock has increased by 13.0% and is now trading at $12.93.

How do I buy shares of ConvaTec Group?

Shares of CNVVY stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Company Calendar

• Ex-Dividend for 10/16 Dividend: 8/22/2025
• Record date for 10/16 Dividend: 8/25/2025
• Today: 9/13/2025
• Dividend Payable: 10/16/2025

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Medical
• Industry: Medical Instruments & Supplies
• Sub-Industry: N/A
• Current Symbol: OTCMKTS:CNVVY
• CIK: 1694271
• Web: www.convatecgroup.com
• Phone: 441189528100
• Fax: N/A
• Employees: 10,136
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: N/A
• Free Float: N/A
• Market Cap: N/A
• Optionable: Not Optionable
• Beta: N/A